...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >EVALUATION OF ANTI-OBESITY ACTIVITY OF SOLASODINE IN HIGH FAT DIET-INDUCED OBESITY IN RAT
【24h】

EVALUATION OF ANTI-OBESITY ACTIVITY OF SOLASODINE IN HIGH FAT DIET-INDUCED OBESITY IN RAT

机译:高脂饮食诱导的肥胖大鼠中茄固碱抗肥胖活性的评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: This study was planned to study the anti-obesity activities of solasodine on high fat (HF) diet-induced obese rats. Methods: Wistar rats were divided into six groups. Control group (Group 1) received normal diet and 0.5 % CMC (5 ml/kg). HF control group (Group 2) received HF diet. Group 3 received orlistat (25 mg/kg body weight per oral). Group 4, 5 and 6 received 25, 50 and 100 mg/kg body weight solasodine respectively. Treatment was given for 6 w to the respective group along with HF diet. Body weight, food intake and abdomen circumference was measured every week for 6 w. On day 42, the serum biochemical parameters like blood glucose and insulin, serum leptin, total cholesterol and triglyceride were evaluated. Animals were sacrificed with overdose of diethyl ether. The liver and retroperitoneal adipose tissues were removed and weighed immediately. Results: Treatment with solasodine at dose of 50 mg/kg and 100 mg/kg significantly (p<0.001) reduced body weight, abdomen circumference and retroperitoneal adipose tissue weight as compared to the HF diet control group. Solasodine also significantly reduced serum total cholesterol, triglyceride and glucose level as compared to HF diet control group (***p<0.001, **p<0.01, *p<0.05 when compared with normal control. ###p<0.001, #p<0.05 when compared with high fat control). In addition, it also inhibited the induction of fatty liver with accumulation of hepatic triglyceride. Conclusion: Solasodine exhibited anti-obesity effect by showing a reduction in body weight, abdomen circumference, total cholesterol level, triglyceride level and glucose level in high-fat diet fed rats.
机译:目的:本研究旨在研究索拉索定对高脂饮食诱导的肥胖大鼠的抗肥胖作用。方法:Wistar大鼠分为六组。对照组(第1组)接受正常饮食和0.5%CMC(5 ml / kg)。 HF对照组(第2组)接受HF饮食。第3组接受奥利司他(每口服25 mg / kg体重)。第4、5和6组分别接受25、50和100 mg / kg体重的solaso​​dine。 HF饮食同时给予各组6 w的治疗。每周测量体重,食物摄入量和腹围6 w。在第42天,评估血清生化参数,例如血糖和胰岛素,血清瘦素,总胆固醇和甘油三酸酯。用过量的乙醚处死动物。取出肝脏和腹膜后脂肪组织并立即称重。结果:与HF饮食对照组相比,以50 mg / kg和100 mg / kg的剂量服用solaso​​dine可以显着(p <0.001)降低体重,腹部围和腹膜后脂肪组织的重量。与HF饮食对照组相比,索拉索定还显着降低血清总胆固醇,甘油三酸酯和葡萄糖水平(与正常对照组相比,*** p <0.001,** p <0.01,* p <0.05,### p <0.001,与高脂控制相比,#p <0.05)。另外,它还抑制了脂肪肝的诱导并伴有肝甘油三酸酯的积累。结论:Solaso​​dine通过降低高脂饮食喂养的大鼠的体重,腹部围,总胆固醇水平,甘油三酸酯水平和葡萄糖水平而表现出抗肥胖作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号